These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 23101624)

  • 41. [Ribosomes and antibiotics. I. Structure and functioning of ribosomes].
    Delaunay J; Schapira G
    Nouv Presse Med; 1974 Oct; 3(35):2251-5. PubMed ID: 4617858
    [No Abstract]   [Full Text] [Related]  

  • 42. Co-produced natural ketolides methymycin and pikromycin inhibit bacterial growth by preventing synthesis of a limited number of proteins.
    Almutairi MM; Svetlov MS; Hansen DA; Khabibullina NF; Klepacki D; Kang HY; Sherman DH; Vázquez-Laslop N; Polikanov YS; Mankin AS
    Nucleic Acids Res; 2017 Sep; 45(16):9573-9582. PubMed ID: 28934499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-resolved binding of azithromycin to Escherichia coli ribosomes.
    Petropoulos AD; Kouvela EC; Starosta AL; Wilson DN; Dinos GP; Kalpaxis DL
    J Mol Biol; 2009 Jan; 385(4):1179-92. PubMed ID: 19071138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotics that target protein synthesis.
    McCoy LS; Xie Y; Tor Y
    Wiley Interdiscip Rev RNA; 2011; 2(2):209-32. PubMed ID: 21957007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypersensitivity of Rhodobacter sphaeroides ribosomes to protein synthesis inhibitors: structural and functional implications.
    Sánchez E; Teixidó J; Guerrero R; Amils R
    Can J Microbiol; 1994 Sep; 40(9):699-704. PubMed ID: 7954105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mechanism of drug-dependent ribosome stalling.
    Vazquez-Laslop N; Thum C; Mankin AS
    Mol Cell; 2008 Apr; 30(2):190-202. PubMed ID: 18439898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward the rational design of macrolide antibiotics to combat resistance.
    Pavlova A; Parks JM; Oyelere AK; Gumbart JC
    Chem Biol Drug Des; 2017 Nov; 90(5):641-652. PubMed ID: 28419786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythromycin leads to differential protein expression through differences in electrostatic and dispersion interactions with nascent proteins.
    Nguyen HL; Pham DL; O'Brien EP; Li MS
    Sci Rep; 2018 Apr; 8(1):6460. PubMed ID: 29691429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elongation factors in protein biosynthesis.
    Andersen GR; Nissen P; Nyborg J
    Trends Biochem Sci; 2003 Aug; 28(8):434-41. PubMed ID: 12932732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition.
    Gagnon MG; Roy RN; Lomakin IB; Florin T; Mankin AS; Steitz TA
    Nucleic Acids Res; 2016 Mar; 44(5):2439-50. PubMed ID: 26809677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Translation and protein synthesis: macrolides.
    Katz L; Ashley GW
    Chem Rev; 2005 Feb; 105(2):499-528. PubMed ID: 15700954
    [No Abstract]   [Full Text] [Related]  

  • 52. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
    Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
    EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells.
    Chittum HS; Champney WS
    Curr Microbiol; 1995 May; 30(5):273-9. PubMed ID: 7766155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statics of the ribosomal exit tunnel: implications for cotranslational peptide folding, elongation regulation, and antibiotics binding.
    Fulle S; Gohlke H
    J Mol Biol; 2009 Mar; 387(2):502-17. PubMed ID: 19356596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetically encoded but nonpolypeptide prolyl-tRNA functions in the A site for SecM-mediated ribosomal stall.
    Muto H; Nakatogawa H; Ito K
    Mol Cell; 2006 May; 22(4):545-52. PubMed ID: 16713584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacterial ribosomal subunit synthesis: a novel antibiotic target.
    Champney WS
    Curr Drug Targets Infect Disord; 2001 May; 1(1):19-36. PubMed ID: 12455231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel tetrapeptide inhibitors of bacterial protein synthesis produced by a Streptomyces sp.
    Brandi L; Lazzarini A; Cavaletti L; Abbondi M; Corti E; Ciciliato I; Gastaldo L; Marazzi A; Feroggio M; Fabbretti A; Maio A; Colombo L; Donadio S; Marinelli F; Losi D; Gualerzi CO; Selva E
    Biochemistry; 2006 Mar; 45(11):3692-702. PubMed ID: 16533052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical 23S rRNA interactions for macrolide-dependent ribosome stalling on the ErmCL nascent peptide chain.
    Koch M; Willi J; Pradère U; Hall J; Polacek N
    Nucleic Acids Res; 2017 Jun; 45(11):6717-6728. PubMed ID: 28369621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A crevice adjoining the ribosome tunnel: hints for cotranslational folding.
    Amit M; Berisio R; Baram D; Harms J; Bashan A; Yonath A
    FEBS Lett; 2005 Jun; 579(15):3207-13. PubMed ID: 15943964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of a number of classes of 50S inhibitors on stop codon readthrough during protein synthesis.
    Thompson J; Pratt CA; Dahlberg AE
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4889-91. PubMed ID: 15561874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.